Press Releases
European Medicines Agency Issues Positive Opinion for the Use of IMBRUVICA® (ibrutinib)
AbbVie, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a...
Industry Reports
The 2016 first quarter operating profit of Novo Nordisk increased by 10% in local currencies
Sales increased by 9% in local currencies and by 8% in Danish kroner to DKK 27.2 billion. Sales of Victoza® increased by 15%...
Industry Reports
Abbott to acquire st. Jude medical
Combination will create a premier medical device leader and strengthen abbott's long-term growth potential Acquisition will enhance abbott's global scale and capabilities and...
Industry Reports
Aspen Technology reports Financial Results for the Third Quarter of Fiscal 2016
Aspen Technology, Inc ,a leading provider of software and services to the process industries, today announced financial results for its third quarter of fiscal...
News
Eli Lilly To Participate In Bank Of America Merrill Lynch 2016 Health Care Conference
Eli Lilly and Company will attend the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016. David Ricks, Lilly senior...
Research Insight
Bristol-Myers Squibb’s Opdivo Receives Breakthrough Therapy Designation from US FDA for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Designation based on results of Phase 3 study, CheckMate -141, in which Opdivo met its primary endpoint of overall survival, versus three standard of...
Research Insight
Novartis drug Afinitor® reduces seizures patients with tuberous sclerosis complex
Novartis announced results from a Phase III study showing Afinitor®* (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures associated with tuberous...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read